Pharmacy Times

JUNE 6, 2023

Treatment for community-acquired pneumococcal disease is dependent on patient-specific factors, whereas prevention with vaccinations is dependent on age and comorbidities.

Patients 26

Patients 26

Pharmaceutical Technology

OCTOBER 28, 2022

On 24 October, American vaccine developer Vaxcyte shared positive topline data from a Phase I/II study of its multivalent conjugate pneumococcal vaccine VAX-24 , bringing the 24-valent pneumococcal jab one step closer to market. This is in addition to its long-available pneumococcal polysaccharide vaccine PPSV23.

Training 64

Training Marketing Competition FDA 64

European Pharmaceutical Review

SEPTEMBER 26, 2022

Positive top-line Phase III study results from Pfizer’s major 20-Valent Pneumococcal Conjugate Vaccine (20vPnC) indicate that it could help prevent invasive pneumococcal disease (IPD) and pneumonia. The seven serotypes included in 20vPnC vaccine cause most cases of invasive pneumococcal disease (IPD) worldwide.

Safety 77

Safety Medicine Patients Pharmaceutical 77

Pharmacy Times

DECEMBER 13, 2023

Clinical trial results show the immunogenicity, tolerability, and safety of V116 compared to a pneumococcal 20-valent conjugate vaccine for adults who had not previously received a pneumococcal vaccine.

Safety 26

Safety 26

Pharmacy Times

AUGUST 2, 2023

Medical experts discuss clinical, social, and economic obstacles limiting pneumococcal vaccination efforts.

Medical 49

Medical 49

Pharmacy Times

JULY 12, 2023

Key opinion leaders discuss factors leading to the development of novel pneumococcal vaccines.

Leads 26

Leads 26

PM360

AUGUST 29, 2022

make patient’s health information available online within a short period of time, facilitate the electronic exchange of health information to improve the quality of care delivered, and submit clinical quality data to reimbursement authorities as required). HCPs needed to show they could utilize a certified EHR in a meaningful way (i.e.,

Electronics 97

Electronics Patients Medical Healthcare 97

Pharmaceutical Technology

JULY 13, 2022

Furthermore, Orion will oversee the manufacturing of ODM-208 for clinical and commercial supply. In June this year, the US Food and Drug Administration approved Merck’s pneumococcal 15-valent conjugate vaccine, Vaxneuvance, for children aged six weeks to 17 years.

Food and Drug Administration 105

Food and Drug Administration Food Marketing Manufacturing 105

Clarify Health

OCTOBER 24, 2021

Interview with Sapna Prasad, PhD , Senior Director and leader of the Clarify Insights team It is widely recognized that racial and ethnic disparities impact the rate of adult immunization for vaccines like pneumococcal, hepatitis A, hepatitis B, influenza, and human papillomavirus (HPV) vaccines.

Pharma 52

Pharma Education Medical Patients 52

PM360

DECEMBER 20, 2023

The out-of-pocket (OOP) percentage for the same service is lowest in community clinics and highest in general hospitals. In most cases, imported innovative drugs cannot apply for local regulatory approval with global multicenter clinical trial results and a Chinese phase 3 clinical trial is mandatory.

Marketing 105

Marketing Insurance Medical Manufacturing 105

Clarify Health

AUGUST 1, 2023

In support of National Immunization Awareness Month, the Clarify Health Institute explores key aspects of pediatric vaccination trends and reinforces their clinical importance by addressing common misconceptions and presenting insights from empirical analyses of vaccination rates among patients aged 0-2 years.

Safety 52

Safety Education Healthcare Healthcare 52